内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Grogan Donna Roy. Director active across 1 company, notably C4 Therapeutics, Inc.. Cumulatively, 13 reports have been published. Activity tracked since 3 October 2022. The latest transaction was disclosed on 1 April 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Grogan Donna Roy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
5,370 股@ US$2.708.6% 占其流量Common StockSEC:0001470831-26-000345:0
9,609 股@ US$1.51Common StockSEC:0001662579-25-000052:0
9,581 股@ US$1.4359.6% 占其流量Common StockSEC:0001662579-25-000025:0
3,757 股@ US$3.6610.0% 占其流量Common StockSEC:0001662579-25-000004:0
2,474 股@ US$5.569.4% 占其流量Common StockSEC:0001662579-24-000090:0
2,836 股@ US$4.859.7% 占其流量Common StockSEC:0001662579-24-000064:0
1,697 股@ US$8.109.7% 占其流量Common StockSEC:0001662579-24-000036:0
2,108 股@ US$6.529.4% 占其流量Common StockSEC:0001662579-24-000004:0
8,089 股@ US$1.709.9% 占其流量Common StockSEC:0001662579-23-000107:0
4,858 股@ US$2.839.5% 占其流量Common StockSEC:0001662579-23-000066:0
4,298 股@ US$3.209.5% 占其流量Common StockSEC:0001662579-23-000044:0
1,763 股@ US$6.387.9% 占其流量Common StockSEC:0001662579-23-000005:0
819 股@ US$8.695.5% 占其流量Common StockSEC:0001662579-22-000006:0
About Grogan Donna Roy
GROGAN DONNA ROY is a Director of C4 Therapeutics, Inc. (XNAS). She has 11 filings in total, and across the 11 sampled filings the period runs from 2022-10-04 to 2025-04-03, with transactions of the Attribution type and buy and sell amounts of 0.